RE:RE:RE:Could be wrong butQuattro74 wrote: Fred, Toad, I think this is correct we will get some kind of financing deal in place with that 12 mth data. I'm betting it will be a jv with a cancan partner for GBM. Which will also provide us conditional monies for the nmibc phase 2. Without some type of funding deal I don't see an easy way for us to start, and finish, phase 2.
The funding deal will be another PP at the best price the company can manage. It's that simple. Whether 2 patients are enough to loosen the financial market's purse strings remains to be seen. It would help if they have a dynamic new CEO calling the shots to help sell the next $10 million PP. Confidence in management goes a long way to impress the smart money. I don't think the way this company is set up right now that they have the confidence of the market.